1. Introduction
1.1. Market Definition
1.2. Market Segmentation
2. Research Methodology
2.1. Research Data
2.2. Assumptions
3. Executive Summary
3.1. Research Highlights
4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. The threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. Global Neurovascular Devices Market Analysis, By Type
5.1. Introduction
5.2. Embolization Devices
5.3. Angioplasty and Stenting Devices
5.4. Neurovascular Access Devices
5.5. Neurothrombectomy Devices
6. Global Neurovascular Devices Market Analysis, By Applications
6.1. Introduction
6.2. Stenosis
6.3. Arteriovenous Malformation
6.4. Stroke
6.5. Aneurysms
6.6. Others
7. Global Neurovascular Devices Market Analysis, By End-User
7.1. Introduction
7.2. Hospitals
7.3. Ambulatory Surgical Centers
8. Global Neurovascular Devices Market Analysis, By Geography
8.1. Introduction
8.2. North America
8.2.1. United States
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. UK
8.4.2. France
8.4.3. Germany
8.4.4. Italy
8.4.5. Others
8.5. Middle East and Africa
8.6. Asia Pacific
8.6.1. Japan
8.6.2. China
8.6.3. India
8.6.4. Thailand
8.6.5. Taiwan
8.6.6. Indonesia
8.6.7. Others
9. Competitive Environment and Analysis
9.1. Major Players and Strategy Analysis
9.2. Emerging Players and Market Lucrativeness
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Vendor Competitiveness Matrix
10. Company Profiles
10.1. Penumbra
10.2. MicroVention Inc.
10.3. Stryker
10.4. Evasc Neurovascular Enterprises
10.5. Acandis GmbH
10.6. Memry Corporation
10.7. Phenox GmbH
10.8. Spartan Micro Inc.
10.9. Johnson & Johnson
10.10. Shape Memory Medical Inc.